RECRUITING

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To learn more about the experience and wellbeing of people who provide care for cancer patients.

Official Title

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

Quick Facts

Study Start:2025-08-29

Study Completion:2027-11-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05904782

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Provision of signed and dated informed consent form * Stated willingness to comply with all study procedures and availability for the duration of the study * Males and female adults ≥18 years * Able to read and speak English * Caregiver of a patient diagnosed with stage IV solid malignancy, with whom they have been residing for \>6 months * Access to necessary resources for participating in a technology-based intervention (i.e., telephone, internet access)	* Current participation in consistent (self-defined) psychotherapy * Caregivers who are considered part of a vulnerable population (i.e. cognitively impaired (self-reported or patient-reported), pregnant, military personnel) will not be eligible.

Inclusion Criteria

Exclusion Criteria

* Provision of signed and dated informed consent form
* Stated willingness to comply with all study procedures and availability for the duration of the study
* Males and female adults ≥18 years
* Able to read and speak English
* Caregiver of a patient diagnosed with stage IV solid malignancy, with whom they have been residing for \>6 months
* Access to necessary resources for participating in a technology-based intervention (i.e., telephone, internet access)

* Current participation in consistent (self-defined) psychotherapy
* Caregivers who are considered part of a vulnerable population (i.e. cognitively impaired (self-reported or patient-reported), pregnant, military personnel) will not be eligible.

Contacts and Locations

Study Contact

Juliet Kroll

CONTACT

(346) 723-5858

jlkroll@mdanderson.org

Principal Investigator

Juliet Kroll

PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Study Locations (Sites)

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030

United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

Juliet Kroll, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-08-29

Study Completion Date2027-11-01

Study Record Updates

Study Start Date2025-08-29

Study Completion Date2027-11-01

Terms related to this study

Additional Relevant MeSH Terms

Cancer